Ross Kedl, PhD

Professor of Immunology & Microbiology
University of Colorado

Ross KedlDr. Kedl received his PhD in 1997 in the Department of Laboratory Medicine and Pathology at the University of Minnesota in Minneapolis. Before joining the Faculty at the University of Colorado, Dr. Kedl was at 3M Pharmaceuticals working in their small molecule immune response modifier program. In his three years there, he spearheaded efforts at developing novel vaccine adjuvants, resulting in numerous publications and patents in the area of vaccine technology. Dr. Kedl returned to the academic sector in 2004 by joining the faculty in the Integrated Department of Immunology at the University of Colorado Health Sciences Center and National Jewish Medical Research Center where he continues to pursue the discovery and development of novel and clinically applicable vaccine technology. He is also the founder of a start-up pharmaceutical company, ImmuRx Inc., which focuses on developing therapeutic vaccines against chronic infectious diseases, such as HIV and cancer.

Biography from University of Colorado.

IDIGH Calendar

<<  <  April 2019  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
  1  2  4  6  7
  8  9111314
151618192021
22232428
2930     

Upcoming Events

Latest IDIGH Publications

  1. Kendall, E. A., Sahu, S., Pai, M., Fox, G. J., Varaine, F., Cox, H., Cegielski, J. P., Mabote, L., Vassall, A. & Dowdy, D. W.
    (2019)
    .
    What will it take to eliminate drug-resistant tuberculosis?
    .
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
    ,
    vol
    .
    23
    ,
    p
    .
    535-546
    .
  2. Chung, C.-F., Kitzler, T., Kachurina, N., Pessina, K., Babayeva, S., Bitzan, M., Kaskel, F., Colmegna, I., Alachkar, N., Goodyer, P., Cybulsky, A. V. & Torban, E.
    (2019)
    .
    Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis
    .
    PloS one
    ,
    vol
    .
    14
    ,
    p
    .
    e0216426
    .
  3. Lu, Y., Joseph, L., Bélisle, P., Sawatwong, P., Jatapai, A., Whistler, T., Thamthitiwat, S., Paveenkittiporn, W., Khemla, S., Van Beneden, C. A., Baggett, H. C. & Gregory, C. J.
    (2019)
    .
    Pneumococcal pneumonia prevalence among adults with severe acute respiratory illness in Thailand - comparison of Bayesian latent class modeling and conventional analysis
    .
    BMC infectious diseases
    ,
    vol
    .
    19
    ,
    p
    .
    423
    .
  4. Kaur, N., Dendukuri, N., Fellows, L. K., Brouillette, M.-J. & Mayo, N.
    (2019)
    .
    Association between cognitive reserve and cognitive performance in people with HIV: a systematic review and meta-analysis
    .
    AIDS care
    ,
    p
    .
    1-11
    .
  5. Logie, C. H., Williams, C. C., Wang, Y., Marcus, N., Kazemi, M., Cioppa, L., Kaida, A., Webster, K., Beaver, K., de Pokomandy, A. & Loutfy, M.
    (2019)
    .
    Adapting stigma mechanism frameworks to explore complex pathways between intersectional stigma and HIV-related health outcomes among women living with HIV in Canada
    .
    Social science & medicine (1982)
    ,
    vol
    .
    232
    ,
    p
    .
    129-138
    .
More publications